1.866.648.2767
    info@tabularasahealthcare.com

    Texas Retailer H-E-B Names Tabula Rasa HealthCare Subsidiary Company PrescribeWellness as the 2019 Service Vendor of the Year

    Investors - Press Releases

    << Back
    View printer-friendly version

    Texas Retailer H-E-B Names Tabula Rasa HealthCare Subsidiary Company PrescribeWellness as the 2019 Service Vendor of the Year

    24 Oct 2019
    PrescribeWellness recognized for its continued dedication to empower community pharmacy

    MOORESTOWN, N.J., Oct. 24, 2019 (GLOBE NEWSWIRE) -- Tabula Rasa HealthCare® (“TRHC”) (NASDAQ: TRHC), a healthcare technology company advancing the field of medication safety, today announced that its subsidiary company, PrescribeWellness® (“PW”),  received the 2019 Service Vendor of the Year from retailer H-E-B, at its Annual Pharmacy Conference & Awards Dinner

    The H-E-B Service Vendor of the Year is awarded based on several criteria including: Trust, Innovation, Responsiveness, Forward Thinking and Shared Vision.

    “As the significance of preventive care is proven and community pharmacy quickly becomes the most accessible wellness destination, PrescribeWellness’ suite of solutions enables pharmacists to successfully transition to value-based care,” states TRHC Chairman and CEO, Calvin H. Knowlton, PhD. “We are proud to be a partner with H-E-B supporting their primary focus to improve pharmacy efficiency and patient outcomes across the state of Texas. We look forward to a continued partnership.”  

    H-E-B pharmacies utilize a variety of PrescribeWellness’ cloud-based solutions including the Patient Engagement Center, outbound patient communications, PrescribeCare, VaccineComplete and PrescribeMedicare to drive adherence, loyalty and patient care.

    “H-E-B’s innovative approach to patient care has been recognized and admired by all in the industry,” said Alphonse J. Sasso, vice president of chain sales, at PrescribeWellness. “We are honored to have received this award and are dedicated to continuing to bring forward-thinking and value-added solutions to all of our partners throughout the industry.”

    About Tabula Rasa HealthCare
    TRHC (NASDAQ:TRHC) is a leader in providing patient-specific, data-driven technology and solutions that enable healthcare organizations to optimize medication regimens to improve patient outcomes, reduce hospitalizations, lower healthcare costs and manage risk. TRHC provides solutions for a range of payers, providers and other healthcare organizations.  For more information, visit TRHC.com.

    About PrescribeWellness
    TRHC’s PrescribeWellness is a leading cloud-based patient relationship management solutions company that facilitates collaboration between more than 10,000 pharmacies, payers, providers, pharmaceutical companies and their patients for better health. To learn more about the please visit, tabularasahealthcare.com/our-solutions/technology-products/.

    Forward-Looking Statement
    This press release includes forward-looking statements that we believe to be reasonable as of today’s date.  Such statements are identified by use of the words “anticipates,” “believes,” “estimates,” “expects,” “intends,” “plans,” “predicts,” “projects,” “should,” and similar expressions.  These forward-looking statements are based on management’s expectations and assumptions as of the date of this press release.  These forward-looking statements include, among other things, our goals and expectations regarding the combined company and the integration of PW into TRHC, the expected synergies from the combined company and the expected financial and operating performance of TRHC following the completion of the acquisition.  Actual results might differ materially from those explicit or implicit in the forward-looking statements. Important factors that could cause actual results to differ materially include: the risk that we may not be able to achieve our expectations for the combined companies due to challenges in integration and inability to retain key employees; fluctuations in our financial results; the acceptance and use of our products and services by PACE organizations and pharmacies; the need to innovate and provide useful products and services; risks related to changing healthcare and other applicable regulations; our ability to maintain relationships with a specified drug wholesaler; increasing consolidation in the healthcare industry; managing our growth effectively; our ability to adequately protect our intellectual property; the requirements of being a public company; our ability to recognize the expected benefits from acquisitions on a timely basis or at all; and the other risk factors set forth from time to time in our filings with the Securities and Exchange Commission (“SEC”),  including those factors discussed under the caption “Risk Factors” in our most recent annual report on Form 10-K, filed with the SEC on March 1, 2019,  and in subsequent reports filed with or furnished to the SEC, copies of which are available free of charge within the Investor Relations section of the TRHC website http://ir.trhc.com or upon request from our Investor Relations Department. TRHC assumes no obligation and does not intend to update these forward-looking statements, except as required by law, to reflect events or circumstances occurring after today’s date.

    Media Contact
    Amanda Bednar
    abednar@trhc.com
    T: (856) 912-5714

    Dianne Semingson
    dsemingson@trhc.com
    T: (415) 547-7099
    Investors
    Bob East or Asher Dewhurst
    Westwicke Partners
    tabularasa@westwicke.com
    T: (443) 213-0500

    TRHC-logo fin.png

    Source: Tabula Rasa HealthCare, Inc.